Skip to main content

Where it All Began

Dr Shiddiky will seek to develop a new diagnostic tool for the early detection of cancer. The tool is focused on isolating, detecting and characterising “circulating tumour cells (CTCs)” in the bloodstream, which have been shown to correlate with survival outcomes and response to therapy.

“I have focused my research in this area over the last several years, and have contributed significantly to develop several microfluidic strategies for molecular and cellular biomarker analysis” Dr Shiddiky said.

“This translational-focused research proposal is centred on the electric-filed induced microfluidic phenomenon to specifically isolate, detect and characterise CTCs in cancer patients, with the ultimate goal of implementing this technology as a standard diagnostic tool for cancer patients undergoing systemic therapy.”